158 related articles for article (PubMed ID: 793966)
1. [Clinical aspects of hypertension under contraceptive steroids].
Kaulhausen H; Klingsiek L
Fortschr Med; 1976 Dec; 94(34):2005-13. PubMed ID: 793966
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
3. [Oral contraceptives and arterial hypertension].
Losse H; Risse E; Wessels F
Med Klin; 1974 Dec; 69(50):2043-50. PubMed ID: 4374645
[TBL] [Abstract][Full Text] [Related]
4. [Changes of the renin-angiotensin-aldosterone system under contraceptive steroids. Contribution to the etiology of hypertension under hormonal contraceptives].
Kaulhausen H; Klingsiek L; Breuer H
Fortschr Med; 1976 Nov; 94(33):1925-30. PubMed ID: 186375
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
7. [Oral contraceptives, hypertension and nephrosclerosis].
Girndt J
Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives.
McAreavey D; Cumming AM; Boddy K; Brown JJ; Fraser R; Leckie BJ; Lever AF; Morton JJ; Robertson JI; Williams ED
Clin Endocrinol (Oxf); 1983 Feb; 18(2):111-8. PubMed ID: 6851195
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Saruta T; Nakamura R; Nagahama S; Suzuki H; Kondo K
Gynecol Obstet Invest; 1981; 12(1):11-20. PubMed ID: 7019015
[TBL] [Abstract][Full Text] [Related]
11. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and oral contraceptives.
Broughton Pipkin F; Hunter JC; Oats J; Symonds M
Br Med J; 1978 Jul; 2(6132):278. PubMed ID: 678905
[No Abstract] [Full Text] [Related]
13. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
Hollenberg NK; Williams GH; Burger B; Chenitz W; Hoosmand I; Adams DF
Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
[TBL] [Abstract][Full Text] [Related]
14. Malignant hypertension with irreversible renal failure due to oral contraceptives.
Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
[TBL] [Abstract][Full Text] [Related]
15. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
Weinberger MH; Kramer NJ; Grim CE; Petersen LP
J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.
De Leo V; la Marca A; Morgante G; Lucani B; Nami R; Ciotta L; Cianci A; Petraglia F
Contraception; 2001 Sep; 64(3):145-8. PubMed ID: 11704092
[TBL] [Abstract][Full Text] [Related]
17. Plasma-aldosterone during oral-contraceptive therapy.
Beckerhoff R; Vetter W; Armbruster H; Luetscher JA; Siegenthaler W
Lancet; 1973 Jun; 1(7814):1218-9. PubMed ID: 4122566
[No Abstract] [Full Text] [Related]
18. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Gaspard UJ; Deville JL; Dubois M
Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
[TBL] [Abstract][Full Text] [Related]
19. Oestrogens and hypertension.
Roberts JM
Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
[TBL] [Abstract][Full Text] [Related]
20. Current status of contraceptive steroids and the intrauterine device.
Mishell DR
Clin Obstet Gynecol; 1974 Mar; 17(1):35-51. PubMed ID: 4596680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
